[Skip to Main Content]

Secretary John M. Colmers

Maryland Crown Logo

Governor Martin O'Malley and Lt. Governor Anthony G. Brown

 Contact Us

Department of Health & Mental Hygiene

         Home FAQs | About Secretary Colmers | Secretary Colmers Welcome Message

                             Today is

Maryland Commission on Kidney Disease

 
 

Menu

Home
Commission Regulations
About
The Commission 
Facility Information
Publications
For Patients
Kidney Disease Program
Forms
Related Links
Miscellaneous
Frequently Asked Questions
Contact Information 
Terms of Use
Other Licensing Boards
DHMH Home
 

 

 

Page Last Updated:

12/17/2009


 

Facility Information


Attention: For New Facilities
List of Dialysis Centers in Maryland
Important Information for Hemodialysis Patients
Life Threatening Vascular Hemorrhage Prevention Statement
Tips For Frequent No Show Patients
General Guidelines For Involuntary Patient Transfer and Discharge
MARC Quick Tips
Checklist for New Facility Documentation
Internal Staffing Exception Report
Facility Update Information
Criteria for Payment by Kidney Disease Program
Download Template for Transplant Letter
Survey Forms PDF or EXCEL


Life Threatening Vascular Access Hemorrhage Prevention Statement

Patients with end-stage kidney failure frequently require hemodialysis, a medical treatment that replaces the function of the kidneys by filtering blood and removing waste products. The site at which blood is removed from and returned to the body is called a vascular access site, which is typically created through a graft, fistula or a central venous catheter. Vascular access sites are associated with many potential complications, including infection and blood clotting. Severe hemorrhagic shock or death from excessive blood loss is one of the most serious and preventable of these complications. It can occur when a blood vessel graft or AV fistula erodes through the skin, a false aneurysm develops at the access site, or a central venous catheter is accidentally cut or dislodged. Use of any vascular access by untrained individuals for blood sampling, intravenous substance abuse by dialysis patients, or access site infections are other important factors, which may result in vascular access failures, potentially fatal hemorrhages or overwhelming septicemia.

Lethal vascular access related hemorrhagic complications occur in a very small percentage of hemodialysis patients. According to a recent study, 24 Maryland residents between 28 and 85 years of age died as a result of severe and uncontrolled bleeding from vascular access sites between the years 2000 and 2006. Of these patients, 63% were male and 75% were African American.

Some deaths from vascular access hemorrhage may have been preventable. An essential component of patient care is education, and hemodialysis patients should have repeated educational sessions concerning the clinical signs of vascular access site complications, including graft failure, infection or aneurysm formation. They also need to be clearly instructed that their vascular access is their dialysis lifeline and should only be used for treatment purposes by trained personnel for dialysis exclusively.

Furthermore, we recommend that nephrologists, vascular access surgeons and dialysis centers provide ongoing education on the risks of vascular access hemorrhage and the warning signs of graft failures. A more comprehensive policy on life saving measures in the event of severe hemorrhage from a vascular access site will be developed by the professional dialysis community in cooperation with the Maryland Kidney Commission.

 

 

Links marked with This is a .pdf file and requires Acrobat Reader are PDF.  Download Adobe Acrobat Reader for viewing .pdf files

General Information: (410) 764-4799
Technical Problems/Site Suggestions, send email to: The Web Master
MD Relay Number: 1-800-735-2258

(For best results, view at 800 x 600 with Microsoft Internet Explorer)
Copyright © 2002 Maryland Department of Health and Mental Hygiene (DHMH)